959986-12-0 Usage
Uses
Used in Pharmaceutical Industry:
4-(4-methylpiperazin-1-yl)pyridin-2-amine serves as a key intermediate in the synthesis of various pharmaceutical drugs. Its incorporation into drug molecules is driven by its potential to enhance pharmacological properties, such as antiviral, antifungal, and anticancer activities. 4-(4-methylpiperazin-1-yl)pyridin-2-amine's unique structure allows it to form critical interactions within biological systems, contributing to the effectiveness of the resulting medications.
Used in Chemical Research:
In the realm of chemical research, 4-(4-methylpiperazin-1-yl)pyridin-2-amine is utilized as a substrate in organic synthesis reactions. Its versatile chemical properties make it suitable for a range of reactions, facilitating the creation of new organic compounds with potential applications in various fields.
Used as a Ligand in Coordination Chemistry:
4-(4-methylpiperazin-1-yl)pyridin-2-amine also holds promise as a ligand in coordination chemistry. Its ability to form stable complexes with metal ions is of interest to researchers, as these complexes can exhibit unique properties and be applied in areas such as catalysis, materials science, and sensor development.
Overall, 4-(4-methylpiperazin-1-yl)pyridin-2-amine is a multifaceted compound with broad applications across different industries, particularly in pharmaceuticals and chemical research, where its unique structure and properties are harnessed to develop new drugs, materials, and chemical processes.
Check Digit Verification of cas no
The CAS Registry Mumber 959986-12-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,9,9,8 and 6 respectively; the second part has 2 digits, 1 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 959986-12:
(8*9)+(7*5)+(6*9)+(5*9)+(4*8)+(3*6)+(2*1)+(1*2)=260
260 % 10 = 0
So 959986-12-0 is a valid CAS Registry Number.
959986-12-0Relevant academic research and scientific papers
HETEROCYCLIC COMPOUNDS AND USE THEREOF AS MODULATORS OF TYPE III RECEPTOR TYROSINE KINASES
-
Paragraph 0994, (2016/08/03)
Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.
IMIDAZO-CONDENSED BICYCLES AS INHIBITORS OF DISCOIDIN DOMAIN RECEPTORS (DDRS)
-
Page/Page column 101, (2015/02/02)
The invention provides a compound of formula (I) (Formula (I)) or a tautomeric form, stereochemically isomeric form, N-oxide, pharmaceutically acceptable salt or solvate thereof, wherein R2, R3, R4, Ra, Rb
AMINOTHIAZOLE DERIVATIVES AS INHIBITORS OF MARK
-
Page/Page column 18, (2008/06/13)
Compounds of formula (I): inhibit microtubule affinity regulating kinase (MARK) and therefore find use in treatment of neurodegenerative diseases associated with hyperphosphorylation of tau.
